High levels of donor‐derived cell‐free DNA in a case of graft‐versus‐host‐disease following liver transplantation

The diagnosis of graft‐versus‐host‐disease (GVHD) after solid organ transplantation is made difficult by its variable clinical presentation and lack of sensitive and specific biomarkers to evaluate the immune state of transplant recipients. Emerging noninvasive diagnostic techniques like the quantification of donor‐derived cell‐free DNA (dd‐cfDNA) for surveillance may improve the current standard‐of‐care. Herein, we report the use of this methodology in a patient with GVHD and corresponding levels of dd‐cfDNA without any evidence of graft injury. Correlation of dd‐cfDNA levels with the clinical course and its novel application here could lead to improvements in the rapid diagnosis of GVHD and in monitoring of response to treatment. Donor derived cell‐free DNA fraction correlates with clinical course in a case of graft‐versus‐host‐disease after liver transplantation.